Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
AssigneeCel-Sci Corporation
InventorsDaniel H. Zimmerman, Eyal Talor, Kenneth Rosenthal
Life of this patent
Estimating the term…
Loading patent…
AssigneeCel-Sci Corporation
InventorsDaniel H. Zimmerman, Eyal Talor, Kenneth Rosenthal
Estimating the term…
The invention is related to peptide constructs, i.e., polypeptides obtained by linking together two or more peptides based on or derived from different molecules, which are useful in the treatment or prevention of cancer or the treatment of autoimmune diseases and compositions containing same, methods for producing same, and methods for using same; wherein the peptide constructs have the formula P1-x-P2 where P2 is a peptide associated with forms of cancer or an autoimmune condition and P1 is a peptide which will bind to a class of immune cells such as dendritic cells. The peptide construct can cause the maturation of immature dendritic cells to a more mature state. The peptide construct or the more mature dendritic cells can be administered to a subject to a modulate or to initiate an immune response against cancer cells, and can be used with dyes, radioisotopes, or therapeutic agents for detection of the immune target and/or treatment of cancer and autoimmune conditions.
A peptide for directing an immune response in a subject as a vaccine or to modulate immune response in an autoimmune disease or cancer, or for maturing dendritic cells, comprising a peptide construct having the formula P1-x-P2, wherein
Dependencies are inferred from the claim text.